Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. That said, here is one stock where Wall Street’s positive outlook is supported by strong fundamentals and two where consensus estimates seem disconnected from reality.
Two Stocks to Sell:
Titan International (TWI)
Consensus Price Target: $11.75 (59.5% implied return)
Acquiring Goodyear’s farm tire business in 2005, Titan (NYSE: TWI) is a manufacturer and supplier of wheels, tires, and undercarriages used in off-highway vehicles such as construction vehicles.
Why Should You Dump TWI?
- Annual revenue growth of 2.5% over the last two years was below our standards for the industrials sector
- Eroding returns on capital suggest its historical profit centers are aging
- High net-debt-to-EBITDA ratio of 6× increases the risk of forced asset sales or dilutive financing if operational performance weakens
Titan International’s stock price of $7.37 implies a valuation ratio of 438.5x forward P/E. Dive into our free research report to see why there are better opportunities than TWI.
Regeneron (REGN)
Consensus Price Target: $833.31 (29% implied return)
Founded by scientists who wanted to build a company where science could thrive, Regeneron Pharmaceuticals (NASDAQ: REGN) develops and commercializes medicines for serious diseases, with key products treating eye conditions, allergic diseases, cancer, and other disorders.
Why Is REGN Not Exciting?
- The company has faced growth challenges as its 6.7% annual revenue increases over the last two years fell short of other healthcare companies
- Free cash flow margin dropped by 20.5 percentage points over the last five years, implying the company became more capital intensive as competition picked up
- Eroding returns on capital suggest its historical profit centers are aging
Regeneron is trading at $645.99 per share, or 13.4x forward P/E. Check out our free in-depth research report to learn more about why REGN doesn’t pass our bar.
One Stock to Watch:
Vulcan Materials (VMC)
Consensus Price Target: $328.81 (25.6% implied return)
Founded in 1909, Vulcan Materials (NYSE: VMC) is a producer of construction aggregates, primarily crushed stone, sand, and gravel.
Why Do We Like VMC?
- Impressive 10.6% annual revenue growth over the last five years indicates it’s winning market share this cycle
- Operating margin improvement of 5.5 percentage points over the last five years demonstrates its ability to scale efficiently
- Free cash flow margin expanded by 5.4 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
At $261.82 per share, Vulcan Materials trades at 27.9x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
